SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-115296
Filing Date
2020-10-15
Accepted
2020-10-15 16:16:50
Documents
34
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029640-1_10q.htm 10-Q 245654
2 EXHIBIT 31.1 tm2029640d1_ex31-1.htm EX-31.1 10036
3 EXHIBIT 31.2 tm2029640d1_ex31-2.htm EX-31.2 9812
4 EXHIBIT 32.1 tm2029640d1_ex32-1.htm EX-32.1 4427
5 EXHIBIT 32.2 tm2029640d1_ex32-2.htm EX-32.2 4402
  Complete submission text file 0001104659-20-115296.txt   1328860

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20200831.xml EX-101.INS 214397
7 XBRL TAXONOMY EXTENSION SCHEMA bzyr-20200831.xsd EX-101.SCH 16068
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bzyr-20200831_cal.xml EX-101.CAL 18500
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bzyr-20200831_def.xml EX-101.DEF 35702
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bzyr-20200831_lab.xml EX-101.LAB 147290
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bzyr-20200831_pre.xml EX-101.PRE 91057
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 201241653
SIC: 2835 In Vitro & In Vivo Diagnostic Substances